Mitochondrial reprogramming via ATP5H loss promotes multimodal cancer therapy resistance.
Song KH, Kim JH, Lee YH, Bae HC, Lee HJ, Woo SR, Oh SJ, Lee KM, Yee C, Kim BW, Cho H, Chung EJ, Chung JY, Hewitt SM, Chung TW, Ha KT, Bae YK, Mao CP, Yang A, Wu TC, Kim TW.
Song KH, et al. Among authors: lee yh, lee hj, lee km.
J Clin Invest. 2018 Aug 31;128(9):4098-4114. doi: 10.1172/JCI96804. Epub 2018 Aug 20.
J Clin Invest. 2018.
PMID: 30124467
Free PMC article.